Viewing Study NCT04807023


Ignite Creation Date: 2025-12-18 @ 8:16 AM
Ignite Modification Date: 2025-12-18 @ 8:16 AM
Study NCT ID: NCT04807023
Status: None
Last Update Posted: 2021-07-19 00:00:00
First Post: 2021-03-16 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Decompensation of Cirrhosis and Iron Metabolism
Sponsor: None
Organization:

Study Overview

Official Title: Decompensation of Cirrhosis and Iron Metabolism
Status: None
Status Verified Date: 2021-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DeCiFer
Brief Summary: Iron is a crucial metal whose metabolism is tightly regulated. Iron deficiency or iron overload are both deleterious at the cellular, organic and systemic levels. In line with the major role of the liver in iron homeostasis, links between iron metabolism and acute on chronic liver failure have been highlighted. Nevertheless, due to the difficulty of accurately assessing iron metabolism in this situation, therapeutic intervention on iron metabolism in this setting is currently not codified.

A better understanding of these mechanisms is therefore essential, in particular by characterizing the impact of exposure to non-transferrin-bound iron in acute on chronic liver failure on short-term mortality.

Overall, a better understanding of the physiopathological mechanisms of iron should allow to optimize the martial balance in this condition and also improve therapeutic approaches.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: